|
"Enhancement of Brain Tumor Immunotherapy by Fas-L RNAi"
|
5R33CA112148-04
|
$348,500
|
$348,500
|
Olivi, Alessandro
|
JOHNS HOPKINS UNIVERSITY
|
|
4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) Phase I Clinical Tr
|
5R43CA132257-02
|
$131,674
|
$131,674
|
MORGAN, Lee
|
DEKK-TEC, INC.
|
|
A Bi-Institutional Pilot Study of Vaccinations for Patients with Low Grade Glioma
|
1R21CA133859-01A2
|
$345,121
|
$345,121
|
OKADA, HIDEHO
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
A Computational Platform for Analyzing and Visualizing Integrated TCGA Data in th
|
5R21CA135870-02
|
$142,200
|
$48,348
|
SANDER, CHRIS
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
A Phase I Trial of CC-5013 (lenalidomide) in Pediatric Patients with Recurrent or
|
ZIA BC 010585
|
$24,404
|
$14,642
|
Warren, Katherine
|
CCR (NCI)
|
|
A Pilot Study of 5-FC and Genetically-Modified Neural Stem Cells to Treat Gliomas
|
1R21CA137639-01A1
|
$365,200
|
$365,200
|
PORTNOW, JANA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
A pilot study of statin therapy and risk of malignant glioma
|
5K07CA127468-02
|
$135,513
|
$135,513
|
Lai, Rose
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
A PTEN-regulated ubiquitin switch controlling TRAIL sensitivity in GBM
|
1R01CA136774-01A1
|
$320,588
|
$320,588
|
Pieper, Russell
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S1
|
$114,606
|
$3,438
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S3
|
$100,000
|
$3,000
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-34
|
$7,326,647
|
$219,799
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
ADAM 17 and glioma-tumor progression and treatment
|
1R01CA129446-01A2
|
$300,875
|
$300,875
|
JIANG, FENG
|
HENRY FORD HEALTH SYSTEM
|
|
ADD ARTICLE H.49., EXCHANGE OF CONFIDENTIAL INFORMATION AND RESEARCH MATERIALS
|
N01CO800001-012
|
$231,187,932
|
$2,865,000
|
ARTHUR, LARRY
|
SAIC-FREDERICK INC:1107088
|
|
Adoptive Immunotherapy for GBM During Hematopoietic Recovery from Temozolomide
|
1R01CA134844-01A2
|
$321,841
|
$321,841
|
MITCHELL, DUANE
|
DUKE UNIVERSITY
|
|
Adult Brain Tumor Consortium (ABTC)
|
1U01CA137443-01
|
$2,000,000
|
$2,000,000
|
GROSSMAN, STUART
|
JOHNS HOPKINS UNIVERSITY
|
|
Adult Neurobehavioral Late Effects of Pediatric Low Grade Brain Tumors
|
1R01CA132899-01A1
|
$403,685
|
$403,685
|
RIS, M
|
BAYLOR COLLEGE OF MEDICINE
|
|
AEG-1: Novel Gene Involved in Malignant Glioma
|
1R01CA134721-01A1
|
$310,213
|
$310,213
|
FISHER, PAUL
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
AGAP2 regulates membrane trafficking and migaration of glioblastoma cells
|
1K22CA124578-01A2
|
$192,024
|
$192,024
|
NIE, ZHONGZHEN
|
UNIVERSITY OF FLORIDA
|
|
Allergic Condition Susceptibility Polymorphisms and Glioma Risk
|
5R01CA122163-02
|
$497,510
|
$497,510
|
SCHWARTZBAUM, JUDITH
|
OHIO STATE UNIVERSITY
|
|
Allergies, Genetic Susceptibility and Adult Glioma Risk
|
5R01CA114205-04
|
$406,175
|
$406,175
|
MICHAUD, DOMINIQUE
|
U OF L IMPERIAL COL OF SCI/TECHNLGY/MED
|
|
Allogeneic glioma vaccine using TGF-beta knockouts
|
5R44CA105964-04
|
$828,132
|
$828,132
|
FAKHRAI, HABIB
|
NOVARX CORPORATION
|
|
American College of Radiology Imaging Network
|
5U01CA080098-11
|
$8,896,390
|
$444,820
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
An Exploratory Study of Biologic and Pathophysiologic Efects of Radiation Therap
|
ZIA BC 010709
|
$97,616
|
$87,855
|
Warren, Katherine
|
CCR (NCI)
|
|
An Integrative Genomics Data Viewer to Support the TCGA Project
|
5R21CA135827-03
|
$205,500
|
$69,870
|
MESIROV, JILL
|
BROAD INSTITUTE, INC.
|
|
An investigation of radial glia as the source of ependymoma stem cells
|
5R01CA129541-03
|
$319,200
|
$319,200
|
Gilbertson, Richard
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Analysis of the p53 in vivo using a unique mouse model
|
5R01CA100193-07
|
$344,459
|
$68,892
|
EVAN, GERARD
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
2P30CA023074-31
|
$4,161,907
|
$249,714
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-31S1
|
$105,806
|
$6,348
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Astrocytic Cancers: How, When, Where?
|
3U01CA084314-10S1
|
$75,305
|
$75,305
|
VAN DYKE, TERRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
ATBC Study
|
ZIA CP010195-03031
|
$804,186
|
$24,126
|
Albanes
|
DCEG (NCI)
|
|
Automatic Three Dimensional (3D) Registration for Enhanced Cancer Management
|
2P01CA087634-06A2
|
$1,423,891
|
$512,601
|
MEYER, CHARLES
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Autophagy in Brain Tumor
|
1R01CA135038-01A2
|
$332,771
|
$332,771
|
YANG, JIN-MING
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Autophagy inhibition as a therapeutic strategy for glioblastoma mutliforme
|
5R21CA133898-02
|
$356,164
|
$356,164
|
AMARAVADI, RAVI
|
UNIVERSITY OF PENNSYLVANIA
|
|
AZD2171 and chemoradiation for newly diagnosed glioblastoma
|
5R01CA129371-03
|
$634,655
|
$634,655
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-20
|
$521,201
|
$5,212
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Bcl-2 family proteins in the ER-mediated apoptosis
|
5K01CA098092-06
|
$124,308
|
$62,154
|
ZONG, WEI-XING
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-08
|
$749,588
|
$7,496
|
DECKER, DAVID
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
BIDMC Research Training Grant in Cancer Radiology
|
5T32CA059367-15
|
$99,433
|
$19,887
|
CLOUSE, MELVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$728,095
|
$36,405
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Biomarkers of survival in glioma epidemiology
|
5R01CA126831-02
|
$424,086
|
$424,086
|
Wiencke, John
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Biomodulation of anticancer drugs targeting DNA
|
5R01CA116491-03
|
$228,000
|
$75,240
|
CARRIER, FRANCE
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
BIOSYNTHETIC KEY STEPS OF ANGUCYCLINE ANTITUMOR DRUGS
|
5R01CA102102-05
|
$246,853
|
$49,371
|
ROHR, JURGEN
|
UNIVERSITY OF KENTUCKY
|
|
Blood Flow MRI for Monitoring Glioma Angiogenesis
|
5R01CA115745-04
|
|
$0
|
ALSOP, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Bone Marrow Stem Cells: Novel Treatment of Human Glioma
|
5R01CA115729-04
|
$265,423
|
$265,423
|
LANG, FREDERICK
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Boronated nucleosides for neutron capture therapy of brain tumors
|
1R01CA127935-01A2
|
$257,964
|
$257,964
|
TJARKS, WERNER
|
OHIO STATE UNIVERSITY
|
|
Brain Irradiation Affects Neuronal Function
|
1R01CA133216-01A2
|
$307,017
|
$307,017
|
Rosi, Susanna
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Brain Tumor Animal Therapeutics Core
|
ZIC BC 011086
|
$607,472
|
$607,472
|
Fine, Howard
|
CCR (NCI)
|
|
Brain Tumor Clinical and Clinical Research Program
|
ZID BC 011098
|
$2,159,900
|
$1,727,920
|
Fine, Howard
|
CCR (NCI)
|
|
BRAIN TUMOR SPORE GRANT
|
5P50CA097257-08
|
$2,252,868
|
$2,252,868
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Brain Tumor Therapeutic Efficacy of Quantitative MR
|
5P01CA085878-07
|
$2,504,121
|
$2,504,121
|
Ross, Brian
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
Total relevant funding to Brain for this search: $142,683,867
|